Malonyl-CoA decarboxylase

From WikiMD's WELLNESSPEDIA

An enzyme involved in fatty acid metabolism

Malonyl-CoA decarboxylase is an enzyme that plays a crucial role in the regulation of fatty acid metabolism. It catalyzes the decarboxylation of malonyl-CoA to produce acetyl-CoA and carbon dioxide. This reaction is important in the context of energy production and lipid biosynthesis.

Function[edit]

Malonyl-CoA decarboxylase is involved in the regulation of fatty acid oxidation and lipogenesis. By converting malonyl-CoA to acetyl-CoA, it helps to modulate the levels of malonyl-CoA, which is a potent inhibitor of carnitine palmitoyltransferase I (CPT1), the enzyme responsible for the transport of fatty acids into the mitochondria for oxidation. Thus, malonyl-CoA decarboxylase indirectly influences the rate of fatty acid oxidation by controlling the availability of malonyl-CoA.

Structure[edit]

The enzyme is a homotetramer, meaning it is composed of four identical subunits. Each subunit contains an active site where the decarboxylation reaction occurs. The structure of malonyl-CoA decarboxylase allows it to bind to its substrate, malonyl-CoA, and facilitate the removal of a carboxyl group, releasing carbon dioxide and forming acetyl-CoA.

Clinical Significance[edit]

Deficiency in malonyl-CoA decarboxylase activity can lead to a rare metabolic disorder known as malonyl-CoA decarboxylase deficiency. This condition is characterized by the accumulation of malonyl-CoA, which can result in developmental delay, cardiomyopathy, and other metabolic complications. Understanding the function and regulation of malonyl-CoA decarboxylase is important for developing potential therapeutic strategies for this disorder.

Regulation[edit]

The activity of malonyl-CoA decarboxylase is regulated by various factors, including the availability of its substrate, malonyl-CoA, and the energy status of the cell. In conditions where energy is required, such as during fasting or exercise, the activity of malonyl-CoA decarboxylase is upregulated to promote fatty acid oxidation and energy production.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.